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Abstract
Rift Valley fever virus (RVFV, family Bunyaviridae) is a mosquito-borne pathogen of both livestock and humans, found
primarily in Sub-Saharan Africa and the Arabian Peninsula. The viral genome comprises two negative-sense (L and M
segments) and one ambisense (S segment) RNAs that encode seven proteins. The S segment encodes the nucleocapsid (N)
protein in the negative-sense and a nonstructural (NSs) protein in the positive-sense, though NSs cannot be translated
directly from the S segment but rather from a specific subgenomic mRNA. Using reverse genetics we generated a virus,
designated rMP12:S-Swap, in which the N protein is expressed from the NSs locus and NSs from the N locus within the
genomic S RNA. In cells infected with rMP12:S-Swap NSs is expressed at higher levels with respect to N than in cells infected
with the parental rMP12 virus. Despite NSs being the main interferon antagonist and determinant of virulence, growth of
rMP12:S-Swap was attenuated in mammalian cells and gave a small plaque phenotype. The increased abundance of the NSs
protein did not lead to faster inhibition of host cell protein synthesis or host cell transcription in infected mammalian cells.
In cultured mosquito cells, however, infection with rMP12:S-Swap resulted in cell death rather than establishment of
persistence as seen with rMP12. Finally, altering the composition of the S segment led to a differential packaging ratio of
genomic to antigenomic RNA into rMP12:S-Swap virions. Our results highlight the plasticity of the RVFV genome and
provide a useful experimental tool to investigate further the packaging mechanism of the segmented genome.
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Introduction
The Bunyaviridae family is composed of five genera: Orthobunya-
virus, Hantavirus, Nairovirus, Phlebovirus and Tospovirus [1]. Rift Valley
fever virus (RVFV) is a member of the Phlebovirus genus and is a
mosquito-borne pathogen of both livestock and humans that is
found primarily in Sub-Saharan Africa and the Arabian Peninsula.
In ruminants, RVFV disease is characterised by foetal deformities,
abortion and high rates of mortality among young animals that
can approach 100% [2]. In humans infection usually results in a
self-limiting febrile illness, though on occasion it can develop into
retinitis, encephalitis and haemorrhagic disease with an overall 1%
case fatality rate [3].
As with the other viruses of the Phlebovirus genus, RVFV
contains a tripartite RNA genome comprising two negative-sense
and one ambisense segments. The large (L) segment encodes the
viral RNA-dependent RNA polymerase. The medium (M)
segment codes for four proteins in a single open reading frame
(ORF): two nonstructural proteins designated NSm1 and NSm2,
and the virion envelope glycoproteins Gn and Gc, whose synthesis
is dictated by which of five methionine codons are used to initiate
translation [4,5]. The small (S) segment (approx. 1.7 kb) encodes
the nucleocapsid protein (N) and a nonstructural protein (NSs) in
an ambisense manner. The N protein is translated from a
subgenomic mRNA transcribed from the genomic RNA, while
NSs is translated from a subgenomic mRNA transcribed from the
antigenomic (replicative-intermediate) RNA [6,7].
The multifunctional NSs protein plays an important role in the
pathogenesis of RVFV and acts to overcome the host innate
immune response. NSs disrupts host cell metabolism at the
transcriptional level by sequestering the p44 subunit and
degrading the p62 component of the basal transcription factor
TFIIH, while other subunits of the TFIIH core are reduced in
infected cells. As a consequence, TFIIH cannot assemble and its
concentration drops rapidly within the cell, leading to a drastically
reduced transcriptional activity [8,9]. NSs has also been shown to
degrade the double-stranded RNA-dependent protein kinase
(PKR) thereby preventing PKR-mediated phosphorylation of the
PLOS Pathogens | www.plospathogens.org 1 February 2014 | Volume 10 | Issue 2 | e1003922
translation initiation factor eIF2a and allowing the continual
translation of viral proteins [10,11]. More recently, the degrada-
tion of PKR has been demonstrated to be independent of the NSs-
mediated degradation of p62 [12]. To further antagonise host
defence mechanisms, NSs also specifically represses transcriptional
activation of the interferon (IFN)-b promoter early in infection
through its interaction with Sin3A-associated protein 30 (SAP30)
mediated by the transcription factor YY1 [13]. This interaction
maintains the repressor complex of YY1, SAP30 and other Sin3A-
associated factors on the IFN-b promoter. In addition, using a
minigenome system, NSs was shown to inhibit the viral
polymerase [14] and thus could play a role in regulating viral
RNA synthesis. However, despite these multitude of activities, NSs
is not essential for replication in either cultured cells or in animals,
though viruses lacking NSs are attenuated to various degrees in
these systems [15–19].
The ambisense S RNA coding strategy adopted by phlebo-
viruses was originally suggested to provide temporal control over
gene expression [7,20–23] in that NSs would be translated
relatively late in the infectious cycle after replication had
commenced with the synthesis of antigenome RNA. However,
given that the major function of NSs is as an interferon antagonist,
it might be expected that this protein would be required early in
infection. Evidence was presented that for Uukuniemi phlebovirus
(UUKV) some copies of the S antigenome are packaged into
progeny virions [20], and subsequently it was shown that all three
antigenome RNAs were packaged into RVFV particles [24].
Furthermore, it was demonstrated that NSs could be translated
from mRNA transcribed from infecting antigenome RNA [24]. It
was also reported that the ratio of antigenomes to genomes
packaged into virions varied from 1:5 to 1:100, depending on the
cells in which the virus was grown. However, this does not seem an
efficient strategy to express NSs early in infection, as not all
infectious virions would package the S antigenome.
To investigate the ambisense expression strategy of the RVFV
S segment in more detail we asked what the consequences would
be of swapping the N and NSs coding sequences on viral
replication. To this end we created a recombinant virus by
reverse genetics, based on the MP12 attenuated strain of RVFV,
in which the N ORF was inserted into the NSs locus and the NSs
ORF into the N locus. The virus, called rMP12:S-Swap, thus has
an ambisense S segment with N and NSs genes in the opposite
orientation to parental MP12 virus. rMP12:S-Swap was attenu-
ated in mammalian cell cultures and had a small plaque
phenotype. We show that swapping ORFs on the S genomic
RNA led to an increased expression of NSs mRNA and protein in
rMP12:S-Swap-infected cells that had implications for the virus’
ability to persistently infect mosquito cell lines. Interestingly, in
mammalian cells the over-expression of NSs did not lead to an
increased inhibition of host cell protein synthesis or degradation
of PKR. Rearrangement of the S segment derived ORFs also
caused a differential packaging of genomic or antigenomic S
RNA species into progeny virions. We discuss the implications of
these findings for determining RVFV genome packaging and for
understanding the biological role of the RVFV coding strategy in
the mammalian host.
Results
Generation of recombinant viruses
The ambisense S segment of RVFV comprises 39 and 59
terminal untranslated regions, with the coding regions for the N
and NSs proteins separated by an untranslated intergenic region
that contains the signals for mRNA transcription-termination [25].
The S segment genomic RNA is defined as that in which the N
ORF is in the negative-sense and the NSs ORF is in the positive-
sense; hence the N mRNA is transcribed from the genomic RNA
and the NSs mRNA is transcribed from the antigenomic RNA
(Figure 1A). In order to transpose the N and NSs coding sequences
an S segment cDNA was synthesised where the N ORF is in the
positive-sense at the NSs locus, and the NSs ORF is in the
negative-sense at the N locus, but all of the untranslated sequences
were untouched (Figure 1A). The cDNA was cloned into pTVT7
[26] to create the plasmid pTVT7-GS:S-Swap. This plasmid was
used together with transcription plasmids pTVT7-GL and
pTVT7-GM and support plasmids pTM1-N and pTM1-L in
the reverse genetics protocol [27]. A recombinant virus was
obtained and designated rMP12S:Swap. As a control, a recom-
binant form of the parental MP12 virus, called rMP12, was
recovered at the same time.
An RT-PCR approach was used to confirm the structure of the
presumptive swapped S RNA segment within rMP12:S-Swap
(Figure 1B). BHK-21 cells were infected with rMP12 or rMP12:S-
Swap at a multiplicity of infection (MOI) of 1 and total cellular
RNA was extracted at 48 h p.i. The RNA was reverse-transcribed
using a segment specific oligonucleotide targeted towards the 59
end of the S segment (Oligo 1; Figure 1A), and PCR reactions
were designed with oligonucleotides to anneal to the 59 end of the
S segment (Oligo 1) or within the S RNA intergenic region (IGR)
(Oligo 2). When using Oligos 1 and 2 and rMP12 derived cDNA
as a template a product of 918 nt was detected corresponding to
the size of the 59UTR, NSs ORF and IGR. In contrast when
rMP12S:Swap cDNA was used a product of 858 nt was detected
corresponding to the size of the 59UTR, N ORF and IGR. The
cDNA-containing plasmids pTVT7-GS (parental MP12) and
pTVT7-GS:S-Swap (Swap) were used as controls for the RT-
PCR product sizes (Figure 1B). Sequence analysis of RT-PCR
products confirmed the expected sequence of the reconfigured
segment and that no mutations had been introduced during the
cloning or virus rescue processes.
We also generated transcription plasmids in which the NSs
ORF was replaced with that of enhanced green fluorescent protein
Author Summary
Rift Valley fever virus (RVFV) is a mosquito-borne bunya-
virus found primarily in sub-Saharan Africa that can infect
both domestic animals and humans. RVFV has a tripartite
RNA genome that encodes seven proteins. The smallest (S)
segment has an unusual ambisense coding strategy
whereby two genes (for the nucleocapsid N and nonstruc-
tural NSs proteins) are encoded in opposite orientations on
the genomic RNA, and are translated from specific
subgenomic mRNAs. N is the major structural protein of
the virus while NSs is the major virulence factor. To
investigate the biological significance of this coding
arrangement, we used reverse genetics to create a
recombinant virus in which the N and NSs coding
sequences were swapped on the S segment. The recom-
binant virus grew less well in tissue culture cells compared
to the parental virus, and rather than maintain persistence
in insect cells, infection resulted in their death. In addition,
packaging of the modified S genome segment into new
virus particles was altered. We also showed that a foreign
protein could be expressed to high levels when cloned in
place of the NSs gene in the recombinant virus. These
studies have implications for vaccine development and
vector control strategies.
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(eGFP) in both pTVT7-GS and pTVT7-GS:S-Swap, which were
designated pTVT7-GSDNSs:eGFP and pTVT7-GS:S-SwapDNS-
s:eGFP. These constructs were then used in the reverse genetics
protocol to generate NSs-deleted forms of the viruses that
expressed eGFP, called rMP12DNSs:eGFP and rMP12:S-
SwapDNSs:eGFP. Multiple stocks of all recombinant viruses were
prepared in BHK-21 cells and had mean titres of 2.286106 PFU/
ml (rMP12S:Swap), 2.156106 PFU/ml (rMP12:S-SwapDNS-
s:eGFP), 1.516108 PFU/ml (rMP12) and 6.166107 PFU/ml
(rMP12DNSs:eGFP). Titres of rMP12:S-Swap and rMP12:
S-SwapDNSs:eGFP were found to be statistically lower (Student’s
t-test; p.0.05) than that of the parental rMP12 virus (Figure 1C).
The plaque phenotypes of the recombinant viruses produced
after 96 h growth in BHK-21 cells are shown in Figure 1D; the
plaques produced by rMP12:S-Swap and rMP12:S-SwapDNS-
s:eGFP were smaller than those produced by the parental MP12-
derived viruses.
Growth properties of recombinant viruses
The growth properties of rMP12:S-Swap were compared to
those of the parental virus in BHK-21 and A549 cells at high
(5 PFU/cell) and low (0.01 PFU/cell) MOI (Figure 2A). At
different times post infection the tissue culture supernatants were
harvested and virus titres determined by plaque assay in BHK-21
cells. In both cell lines and at both multiplicities of infection the
replication of rMP12S:S-Swap was slower than that of rMP12,
and peak titres at 48 h p.i. were 10- to 1000-fold lower (Figure 2A).
The viruses grew to higher titres in BHK-21 cells (which are
interferon incompetent) compared to A549 cells (which are
interferon competent) presumably because they did not have to
overcome host innate immune defences. It was noted in previous
work in our laboratory that for some attenuated viruses, the higher
the initial infecting MOI, the lower the resulting titre recorded in
certain cell lines [19,28]. This was thought to be caused by an
auto-interference effect associated with the production of defective
Figure 1. Creation of rMP12:S-Swap. A. Schematic of the transcription and replication products of the S segments of rMP12 and rMP12:S-Swap.
The sites at which oligonucleotides 1 and 2 anneal are indicated. B. Agarose gel showing RT-PCR products to confirm structure of S segment. BHK-21
cells were infected with rMP12 (MP12) or rMP12:S-Swap (SWAP) viruses at an MOI of 1. Total cellular RNA was extracted at 48 h p.i., and S-segment
RT-PCR was performed. As a control, PCR on the appropriate cDNA-containing plasmids was performed with the same primers. C. Titres of
recombinant virus stocks from multiple independent preparations were determined by plaque assay in BHK-21 cells. The mean titre and standard
error of n = 4 preparations of each recombinant virus stock are shown (* p.0.05) D. Comparison of plaque sizes of rMP12, rMP12:S-Swap,
rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP on BHK-21 cells. Cell monolayers were fixed at 96 h p.i. with 4% paraformaldehyde and stained with
Giemsa solution.
doi:10.1371/journal.ppat.1003922.g001
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virus particles [19]. We therefore tested the effect of MOI on virus
yield from rMP12- or rMP12:S-Swap-infected BHK-21 cells
infected at MOI ranging from 0.0005 to 5 PFU/cell (Figure 2B).
At 48 h p.i. tissue culture supernatants were harvested and titrated
by plaque assay on BHK-21 cells. As seen previously there was
little effect on virus yield of rMP12 infected at the different
multiplicities, with yields ranging from 1.55 to 2.556108 PFU/ml.
For rMP12:S-Swap the highest yield obtained (2.16108 PFU/ml)
was from cells infected at the lowest MOI, and at higher
multiplicities of infection a decrease in yield by up to 10-fold
was observed (Figure 2B).
The growth of recombinant viruses in which the NSs ORF had
been replaced with that of eGFP were also examined in mosquito
cells (Aedes albopictus C6/36 and U4.4 cells, and Aedes aegypti Ae cells)
at a MOI of 1 (Figure 2C). This was the highest MOI that could be
used because mosquito cells are small and thus there are more cells
per given area of a tissue culture plate; for comparison BHK-21 cells
infected at the sameMOI were included. In all cell lines, viruses that
contained a swapped S-RNA segment (rMP12:S-Swap or rMP12:S-
SwapDNSs:eGFP) produced 10- to 100-fold less virus over a 48 h or
96 h period. It should be noted that initial titres of virus released
from mosquito cells (e.g. at 6 h p.i.) were relatively high in these
experiments because it is not possible to completely remove residual
inoculum by extensive rinsing as the cells do not adhere firmly to the
culture vessels, as noted previously [29].
Protein synthesis in infected cells
BHK-21 cells were infected with the recombinant viruses at a
MOI of 0.01 and cell monolayers harvested at the time points
indicated. Western blotting of cell lysates was performed to
monitor the expression of N, NSs, Gn, and, in the case of the NSs
deletion viruses, eGFP (Figure 3A). This low MOI was used as
preliminary experiments had shown a temporal difference
between N and NSs expression in rMP12-infected cells, which
was not seen at higher MOI (unpublished observations). In
rMP12-infected cells, N protein was clearly detected at 12 h p.i.
with NSs protein faintly detectable at this time point (Figure 3A,
left panel). The intensity of N and NSs bands increased over the
48 h time course. Conversely, in rMP12:S-Swap-infected BHK-21
cells the NSs band was very obvious at 12 h p.i. whereas the N
protein band was barely detectable (Fig 3A, left panel). The
intensity of the NSs band increased over 48 h, and was always
stronger than NSs in the corresponding time point from rMP12-
infected cells. On the other hand, the amount of N detected in
rMP12:S-Swap-infected cells was substantially less than that
detected in rMP12-infected cells at the same time points and the
amount of N protein produced did not increase dramatically over
the 48 h period. There was significantly less Gn glycoprotein
synthesised in rMP12:S-Swap-infected cells at early time points,
and although by 48 h p.i. Gn was clearly detected, its accumu-
lation was less than in rMP12-infected cells (Figure 3A, left panel).
Figure 2. Growth properties of recombinant viruses. A. Viral growth curves in BHK-21 and A549 cells infected with rMP12 or rMP12:S-Swap
(MOI of 0.01 or 5 as indicated). B. The effect of multiplicity of infection on viral yield in BHK-21 cells. Cells were infected with rMP12 or rMP12:S-Swap
at multiplicities from 0.0005 to 5 PFU/cell. Viral supernatants were harvested at 72 h p.i. and titrated by plaque assay. Graphs are presented for one
representative experiment. C. Viral growth curves in mosquito cells. A. albopictus C6/36 and U4.4, and A. aegypti Ae, cells were infected with rMP12,
rMP12:S-Swap, rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP at MOI of 1; BHK-21 cells were similarly infected as a control.
doi:10.1371/journal.ppat.1003922.g002
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Figure 3. Protein expression by recombinant viruses. A.Western blot analysis of proteins synthesised in BHK-21 cells infected with rMP12 (M),
rMP12:S-Swap (S), rMP12DNSs:eGFP (MD) or rMP12:S-SwapDNSs:eGFP (SD) at MOI of 1. Cell lysates, prepared at the indicated h p.i., were fractionated
by SDS-PAGE, and after transfer, membranes were reacted with rabbit antibodies specific for N, NSs, Gn or eGFP as indicated. Anti-tubulin antibodies
Reconfiguring the RVFV Ambisense S Genome Segment
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To assess if the difference in N expression between the two
viruses could be an effect of the increased early synthesis of NSs
(due to the swapping of the N and NSs ORFs) we compared
protein synthesis by the two NSs-deleted viruses, rMP12DNSs:
eGFP and rMP12:S-SwapDNSs:eGFP, that contain eGFP in the
place of the NSs coding sequence (Figure 3A, right panel). Similar
to results with NSs-expressing viruses, accumulation of N and Gn
was much lower in rMP12:S-SwapDNSs:eGFP-infected cells,
whereas the expression of eGFP mimicked that of NSs. These
results suggest that the reduced expression of N and Gn was not
due to the amount or timing of NSs production.
We also visualised eGFP fluorescence directly in cells infected
with rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP over 48 h.
Images were recorded at the same brightness setting on the
microscope. At all-time points, the intensity of eGFP fluorescence
observed in rMP12:S-SwapDNSs:eGFP-infected cells was signifi-
cantly greater than that in rMP12DNSs:eGFP-infected cells
(Figure 3B). These data corroborate the western blot results
shown above.
Protein synthesis was also examined in the mosquito cell lines.
No NSs or eGFP protein was detected by western blotting in any
cell line infected with rMP12 or rMP12DNSs:eGFP other than
NSs in C6/36 cells, whereas N protein was readily detectable and
increased over the time course in all cell lines (Figure 3C, upper
panel). It was noted that N protein expression was rather lower in
infected Ae cells compared to the A. albopictus cell lines. No eGFP
fluorescence was observed in any of the cell lines (Figure 3D, upper
panel). However, when mosquito cells were infected with
rMP12:S-Swap NSs protein expression was readily detected in
U4.4. and Ae cells, and levels of NSs were dramatically increased
in C6/36 cells compared to rMP12 infected cells (Figure 3C, lower
panel). eGFP protein was also detected in the three mosquito cell
lines infected with rMP12:S-SwapDNSs:eGFP. N protein could
also be detected, at lower levels compared to rMP12 infection but
its expression was again particularly weak in infected Ae cells.
eGFP fluorescence was also observed by microscopic examination
of infected cells though was weaker in Ae cells (Figure 3D, lower
panel).
NSs localisation and filament formation
A characteristic feature of RVFV NSs protein is that it forms
ribbon-like structures in the nuclei of infected cells [30]. As the
data shown in Figure 3 indicated that there was an augmented
expression of NSs in rMP12:S-Swap-infected cells, we examined
the effect of increased levels of NSs on cellular localisation and
filament formation by immunofluorescent imaging. Vero-E6, C6/
36, U4.4 or Ae cells were infected with rMP12 or rMP12:S-Swap
at an MOI of 1, fixed at 12, 24 or 48 h p.i., and stained with anti-
NSs and anti-tubulin antibodies (Figure 4). In rMP12-infected
Vero-E6 cells thin NSs filaments in the nuclei were seen from 12 h
p.i., and there was little cytoplasmic staining (Figure 4A). By
contrast, in rMP12:S-Swap-infected cells, the nuclear filaments
appeared thicker, and there was more abundant cytoplasmic
staining of NSs, particularly by 24 h p.i. (Figure 4A). The average
thickness of the filaments was determined by measuring the width
of about 50 structures derived from each virus; those of rMP12
averaged 1.19 mm while those produced by rMP12:S-Swap
averaged 2.21 mm (Figure 4B). The difference was statistically
significant (Student’s t-test, p,0.0001).
NSs protein was detected in the nuclei of A. albopictus C6/36
cells infected with both rMP12 or rMP12:S-Swap, though not in
the form of filaments as seen in Vero-E6 cells (Figure 4C, upper
panel, and 4D). Staining appeared granular or as large aggregates.
In the majority of rMP12-infected U4.4 or Ae cells no NSs was
detected, but in rMP12:S-Swap-infected cells aggregates of NSs
were observed in the nuclei (Figure 4D). The infection status of the
rMP12-infected insect cell monolayers was monitored in duplicate
cultures by staining with the anti-N antibody, which showed that
by 48 h p.i. all cells in the monolayer were infected despite a lack
of NSs staining (Figure 4C, lower panel).
Persistence of recombinant viruses in mosquito cell lines
As previously reported by Le´ger et al. [31] infection of mosquito
cells (in this case A. albopictus U4.4 and A. aegypti Aag2 cells) with a
virulent strain of RVFV leads to the establishment of a persistent
infection, though differences in the expression of NSs were
observed in the different cell types. In agreement with their
findings we observed suppression of NSs production in U4.4 cells
and in the Aedes egypti derived Ae cells, and the cells became
persistently infected as shown by detection of N protein (Figure 5)
and of released virus by plaque assay (data not shown) during
sequential passage. The NSs protein was readily detected in
rMP12-infected C6/36 cells for two passages, after which the
abundance of the protein decreased to undetectable levels by
passage 5 through to passage 10 during the establishment of
persistence (Figure 5). The S RNA segment of virus released from
the cells at passages 5 and 10 was amplified by RT-PCR and the
nucleotide sequence determined. In all cases no mutations in the S
segment were observed and the NSs ORF was intact (data not
shown). Different effects were noted in cells infected with
rMP12:S-Swap. C6/36 cells showed dramatic over-expression of
NSs during 3 passages, after which the cells detached from the
substrate and were killed by the infection. In U4.4 cells NSs was
readily detected during establishment of persistent infection, but
the cells showed cytopathic effects that were widespread at passage
3. However, sufficient viable cells were harvested to allow
continued passage, but maintenance of the cells beyond passage
5 was not possible due to the death of all remaining cells. NSs was
detectable at each passage (though not as much as in C6/36 cells)
with the decrease seen at passage 3 due to a reduced number of
cells available to assay. Similarly, the apparent lack of N at passage
3 was due to the reduction in the amount of cells to assay; N was
detectable at both passages 4 and 5. Ae cells did not facilitate
rMP12:S-Swap persistence in the monolayers and the virus was
lost after one passage, evidenced by the lack of N or NSs in cell
lysates (Figure 5).
NSs-induced inhibition of mammalian cell protein and
RNA synthesis
One of the mechanisms of action of NSs in mammalian cells is a
global inhibition of host protein synthesis, mediated at both the
transcriptional level through the degradation of the p62 and the
sequestration of the p44 subunits of TFIIH [8,9], and the
translational level by the degradation of the cellular kinase PKR
were used as a loading control. B. eGFP fluorescence in BHK-21 infected with rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP as above. C.Western blot
analysis of infected mosquito cells. A.albopictus C6/36, U4.4 or A. aegypti Ae cells were infected with recombinant viruses (MOI of 1) and lysates
prepared at different times post infection. Fractionated proteins were probed with the indicated antibodies. D. eGFP fluorescence in mosquito cells
infected with rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP as above. Note that eGFP fluorescence in parts B and D was recorded first and then the
same cells were harvested for the western blotting.
doi:10.1371/journal.ppat.1003922.g003
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[10,11]. We therefore investigated if there was a difference in
protein synthesis inhibition in recombinant virus-infected cells.
A549 (interferon competent) or A549 NPro (interferon incompe-
tent) cells were infected or mock infected with recombinant viruses
at a MOI of 3. At the time points indicated, the cells were labelled
with [35S] methionine/cysteine for two hours, and cell lysates
separated by SDS-PAGE (Figure 6). In rMP12-infected cells the N
protein was identified at 8 h p.i with a faint NSs band visible
above, and by 24 h p.i. there was a marked reduction in
incorporation of radiolabel into host proteins compared to
mock-infected cells. The decrease was even more pronounced at
48 h p.i. in both A549 and A549 NPro cell lines. In rMP12:S-
Swap-infected cells, even though there was considerably greater
synthesis of NSs, there was no increase in host cell protein
synthesis inhibition in comparison to rMP12-infected A549 or
A549 NPro cells. In fact, the degree of inhibition assessed by
densitometry of the lanes was less than in rMP12 infected cells. As
a control, and to show that host protein synthesis inhibition was
largely mediated by the presence of NSs, rMP12DNSs:eGFP and
rMP12:S-SwapDNSs:eGFP cell lysates were also examined. In all
cases, the incorporation of radiolabel over the 48 h duration of the
experiment was greater than in the cells infected with NSs-
expressing viruses.
As protein synthesis reflects the relative abundance of cellular
mRNAs within the cell, we also determined the level of
transcriptional activity in infected cells. A549 cells were infected
with recombinant viruses at MOI of 3 or mock-infected. A dish of
mock-infected cells was also treated with actinomycin D (Act-D) as
a positive control for transcriptional inhibition. One hour before
the time points indicated the uridine analogue 5-ethynyl uridine
(EU) was added to the medium to enable RNA synthesized within
this hour period to be detected by click chemistry [32,33], and
then cells were stained with anti-NSs antibody (Figure 6B, panels
a-h). In rMP12-infected cells punctate nuclear NSs staining was
detected by 8 h p.i. (panel b), and by 12 h p.i. the characteristic
RVFV NSs nuclear filaments were seen in the nuclei of infected
cells (panel d). In rMP12:S-Swap-infected cells, NSs staining was
also detected by 8 h p.i. (panel g), though the staining was
predominantly cytoplasmic rather than nuclear. Irregular and
thicker nuclear filaments were detected in rMP12:S-Swap-infected
cell nuclei from 10 h p.i. onwards along with an increased and
more intense cytoplasmic staining of NSs. In the early stages of
infection (6 h p.i.) RNA synthesis could be detected in the nuclei of
cells infected by either virus. However, RNA staining was
markedly reduced when NSs nuclear filaments were first observed,
similar to that the effect seen when cells were treated with Act D
(Figure 6B, panel j). Thus rMP12:S-Swap inhibited host RNA
synthesis similarly to rMP12.
Next we examined fate of PKR and p62 in A549 cells infected
with rMP12 or rMP12:S-Swap at a MOI of 3 (Figure 7A, upper
panels). At this multiplicity, N and NSs proteins were first detected
at 5 h p.i. in rMP12-infected cells. The amount of PKR detected
started to decrease from 5 h p.i. and was undetectable by 9 h p.i.
The amount of p62 present in the cell lysate was also depleted
starting at 3 h p.i. and was undetectable by 5 h p.i. In rMP12:S-
Swap-infected A549 cells, NSs was first detected at 7 h p.i. and N
at 9 h p.i. Unexpectedly, there was little decrease in the amount of
PKR present in the cells over the 12-hour time course (Figure 7A).
By contrast, a decrease in p62 was noted by 5 h p.i. Thus in both
rMP12- and rMP12:S-Swap-infected cells degradation of p62 was
observed just before NSs was readily detected.
Act-D treatment of infected A549 cells had a small effect on N
and NSs expression by both viruses compared to the levels
observed in the respective untreated cells (Figure 7A, lower
panels). However, more noticeable was that PKR degradation
occurred in rMP12:S-Swap-infected Act-D treated A549 cells
from 4 h p.i. whereas no degradation was seen in uninfected
control cells. Loss of p62 was observed by 3–4 h p.i. for both
viruses, suggesting that ActD treatment induced a decrease in p62
faster than NSs (Figure 7A).
Lastly, we examined the production of interferon in cells
infected with the recombinant viruses at a MOI of 5 after 18 hours
using a biological assay [34]. A549-NPro cells were treated with
UV-inactivated medium from infected cells before being infected
with the interferon-sensitive encephalomyocarditis virus (EMCV).
Subsequently the cells were examined for the protection or not
from EMCV-induced cytopathic effects. rMP12 induced approx-
imately twice as much interferon as rMP12:S-Swap, whereas both
of the NSs deletant viruses generated approximately 64 times as
much interferon (Figure 7B and 7C).
Analysis of viral RNA in infected cells and virus particles
Viral RNAs present in infected cells were examined to ascertain
if the difference in levels of N and NSs protein synthesised by
rMP12- or rMP12S:Swap was mediated at the transcriptional
Figure 4. Intracellular localization of NSs in rMP12- or rMP12:S-Swap-infected cells. A. Vero-E6 cells were infected at MOI of 1, and at the
time points indicated the cells were fixed with 4% paraformaldehyde, followed by co-staining with anti-NSs (green) and anti-tubulin (red) antibodies.
Cells were examined with a Zeiss LSM confocal microscope. B. Width of NSs filaments. The widths of NSs filaments (50) in rMP12- or rMP12:S-Swap
were measured using the LSM Image Browser Software (Carl Zeiss MicroImaging GmbH) and the results presented as the mean width of the filaments
and SEM of the two groups (**** = p,0.0001; see Methods). C. Detection of NSs in mosquito cells infected with rMP12. A.albopictus C6/36, U4.4 or A.
aegypti Ae cells were infected with recombinant viruses (MOI of 1), and at 48 h p.i. the cells were fixed with 4% paraformaldehyde, followed by co-
staining with anti-NSs (green) and anti-tubulin (red) antibodies (upper panels). Duplicate monolayers were stained with anti-N antibodies (lower
panels). D. Detection of NSs in mosquito cells infected with rMP12:S-Swap. Cells were infected and stained with anti-NSs (green) and anti-tubulin
(red) antibodies as above.
doi:10.1371/journal.ppat.1003922.g004
Figure 5. Serial passage of mosquito cells infected with rMP12
or rMP12:S-Swap. A. albopictus C6/36, U4.4 cells or A. aegypti Ae were
infected with rMP12 or rMP12:S-Swap at a MOI of 0.01. Cell monolayers
were passaged (split ratio 1:5) every 5–7 days (when 100% confluency
was observed). Cell extracts were prepared from each passage, proteins
fractionated SDS-PAGE, transferred to a membrane, and blots probed
with anti-N, anti-NSs and anti-tubulin antibodies as indicated. C3/36
cells infected with rMP12:S-Swap died after passage 3.
doi:10.1371/journal.ppat.1003922.g005
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Figure 6. Inhibition of host cell protein and RNA synthesis. A. Protein synthesis. A549 or A549 NPro cells were infected with rMP12, rMP12:S-
Swap, rMP12DNSs:eGFP or rMP12:S-SwapDNSs:eGFP at a MOI of 3. Cells were labelled with 30 mCi [35S] methionine/cysteine for 2 h at the time points
indicated, and cell extracts were fractionated by SDS-PAGE. The positions of the viral N and NSs proteins are shown. Total lane intensities were
measured by densitometry and compared to the mock-infected sample for each virus time course as indicated. B. RNA synthesis. A549 cells were
infected with rMP12 (panels a to d) or rMP12:S-Swap (panels e to h) at a MOI of 3. One hour prior to the time points indicated the uridine analogue 5-
ethynyl uridine (EU) was added to the medium and then cells were fixed in 4% formaldehyde. Cells were processed using Click-iT RNA AF488 Imaging
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Kit (newly synthesised RNA stains green), and then reacted with anti-NSs antibodies and secondary goat anti-rabbit Alexa Fluor 633 antibody (red). As
controls, mock-infected cells were left untreated (i) or treated with actinomycin D (Act D) at 5 mg/ml for 1 h prior to 5-EU treatment (j).
doi:10.1371/journal.ppat.1003922.g006
Figure 7. Effect of RVFV NSs on host cell factors. A. Effect on PKR and p62. A549 cells or A549 cells treated with 5 mg/ml actinomycin D were
infected with rMP12 or rMP12:S-Swap at a MOI of 3, or mock-infected. Cell extracts were prepared at the time points indicated, proteins fractionated
by SDS-PAGE, and blots probed with anti-N, anti-NSs, anti-PKR, anti-p62, and anti-tubulin antibodies as indicated. B. Induction of interferon. A549
cells were infected with rMP12, rMP12DNSs:eGFP, rMP12:S-Swap or rMP12:S-SwapDNSs:eGFP at MOI of 5, and supernatants harvested at 18 h p.i.
After UV treatment, 2-fold dilutions were applied to A549-NPro cells for 24 h, before infection with EMCV. Monolayers were stained with Giesma after
a further 96 h. C. The amount of IFN produced is expressed as relative IFN units (RIU), defined as RIU= 2N where N= the number of two-fold dilutions
of the supernatants that protected the reporter cells from EMCV challenge.
doi:10.1371/journal.ppat.1003922.g007
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level. Northern blot analysis of total cellular RNA from infected
BHK-21 cells was undertaken using strand-specific digoxigenin-
labelled RNA probes for N, NSs and Gn coding regions
(Figure 8A). The NSs(2) probe detected full-length S RNA
(1690 nt) in both rMP12- and rMP12:S-Swap-infected cells,
corresponding to genomic and anti-genomic RNA respectively.
There appeared less anti-genomic S RNA in rMP12:S-Swap
infected cells. The subgenomic NSs mRNA (approximately
900 nt) was also detected with the NSs(2) probe, and was more
abundant in rMP12:S-Swap-infected cell lysates than in cells
infected with the parental virus rMP12. Hybridisation with the
N(+) probe detected the N mRNA (approximately 850 nt) in cells
infected with either rMP12 or rMP12:S-Swap, however to a much
greater extent in rMP12-infected cells. The N(+) probe also detected
rMP12 S anti-genomic RNA and rMP12:S-Swap genomic RNA
species. No detectable difference in the amount of M genomic RNA
Figure 8. Analysis of viral RNAs. A. Intracellular RNAs in infected BHK-21 cells. Cells were infected with rMP12 or rMP12:S-Swap (MOI of 1),
and total cell RNA isolated at 48 h p.i. Northern blotting was performed using DIG-labelled probes complementary to the N, NSs, and Gn coding
regions in the viral genomic (2) sense RNA and the N coding region in the viral anti-genomic (+) sense RNA. The polarity of the RNA detected by each
probe is indicated below the blot: G, genomic sense RNA and AG, anti-genomic sense RNA, defined by the sequence of the 39/59 untranslated
regions. B. S segment derived mRNAs produced in mosquito cells. A. albopictus C6/36, U4.4 cells or A. aegypti Ae were infected with rMP12 or
rMP12:S-Swap at MOI of 1, and total cellular RNA extracted at the indicated times p.i. Northern blotting was performed using the N(+) and NSs(2)
probes. C. Analysis of RNA packaged into virions. RNA was extracted purified rMP12 or rMP12:S-Swap grown in BHK-21 cells, and Northern blotting
performed with the probes as detailed in (A) above. D. Quantitative RT-PCR analysis of viral RNAs. Total cellular RNA (upper panels) or RNA in purified
virus particles (lower panels) of rMP12 or rMP12:S-Swap was analysed using probes specific form the S or M segments as described in Methods. The
results are presented as the percentage of genomic RNA species compared to the total RNA of the same segment. Cell line abbreviations: B, BHK-21;
C, C6/36; U, U4.4; and A, Ae.
doi:10.1371/journal.ppat.1003922.g008
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was detected between the rMP12 or rMP12:S-Swap intracellular
RNA samples using the Gn(2) probe (Figure 8A).
A similar approach was used to examine the N and NSs
subgenomic mRNAs produced in rMP12- or rMP12:S-Swap-
infected C6/36, U4.4 or Ae total cell RNA extracts over a 96 h
time course of infection (Figure 8B). N and NSs mRNAs were
readily detected in C6/36 cells infected with either virus. In
rMP12-infected U4.4 or Ae cells, NSs mRNA was barely
detectable, if at all, reflecting earlier data shown in Figure 3C
that no NSs protein was made during this period. When rMP12:S-
Swap-infected total cell RNA extracts were examined, NSs
message was strongly detected in these cells, whereas the signal
for N mRNA was much weaker (Figure 8B).
The RNA packaged into rMP12 and rMP12:S-Swap virus
particles was also examined by Northern blotting. For rMP12
virion RNA, the N(2) and NSs(2) probes detected S genomic
RNA and the N(+) probe also detected a lesser amount of
packaged antigenomic RNA. Conversely, when rMP12:S-Swap
derived virion RNA was analysed, the N(2) and NSs(2) probes
detected antigenomic S RNA and the N(+) probe detected
genomic sense RNA, which was present in the lesser amounts.
As a control the genomic M RNA was analysed by hybridisation
with the Gn(2) probe and showed similar amounts of virion RNA
were loaded on the gel from rMP12 or rMP12:S-Swap virus
particles (Figure 8C).
The above results suggested that there were different ratios of
genomic to antigenomic S RNA present in infected cells and
packaged into virions. As it is difficult to quantify levels of RNA in
infected cells by Northern blotting, we re-examined the same RNA
samples using strand-specific qRT-PCR (Figure 8D). (Optimisa-
tion of the assay is presented in Supplementary Figures S1 and S2,
and Table S2). Viral genomic or antigenomic S- or M-segment
RNA was selectively amplified with segment-specific tagged
oligonucleotides as described above. In rMP12-infected BHK-21
cells the mean proportion of the two S RNA species was 72.0%
genomic RNA and 28.0% antigenomic RNA. However, when the
rMP12:S-Swap infected-cell BHK-21 RNA was examined the
mean proportion of S genomic RNA was reduced to 23.2% of the
S RNA present in the cell. In contrast there was no difference in
the mean proportions of M segment RNA in either rMP12 or
rMP12:S-Swap infected BHK-21 cells, with 98.9% or 99.1%
genomic RNA and 1.1% or 0.9% antigenomic RNA recorded
respectively (Figure 8D).
Next, we investigated whether the difference in the ratio of
genomic to antigenomic S RNA seen in rMP12- and rMP12:S-
Swap-infected cells was reflected in the RNA packaged into
progeny virions. For rMP12 grown in BHK-21 cells, we observed
mean values of 82% genomic and 18% anti-genomic S RNA,
whereas for rMP12:S-Swap the mean values were 43.7% genomic
and 56.3% anti-genomic RNA. In contrast there was no significant
difference in the proportions of packaged M segment RNAs
between the two viruses: 98.6%:1.4% genomic:antigenomic for
rMP12 and 98.1%:1.9% genomic:antigenomic for rMP12:S-
Swap. We also investigated the RNA species packaged when the
viruses were grown in mosquito cells, and saw similar patterns to
that described for BHK-21 cell grown viruses (Figure 8D).
We analysed these data to determine whether the differences in
RNA populations in total cell RNA and virion RNA were
statistically significant. Five independent RNA preparations were
analysed for each cell type, and the mean percentage of genomic
RNA (defined by the 39 genomic UTR sequence of rMP12) was
calculated. The composition of the RNA population was analysed
using a one-way ANOVA with Tukey’s multiple comparison post-
test; significance was set at p,0.05. The results are summarised in
Table 1 (raw data can be found in Supplementary Table S3 and
S4). In all cell lines tested there was a significant difference in the
percentage of genomic S segment RNA produced within the
infected cell and between the relative amounts of genomic S
segment RNA packaged in virus particles when comparing rMP12
to rMP12:S-Swap. Conversely, there was no significant difference
in the proportion of genomic M segment RNA present in either
rMP12- or rMP12:S-Swap total cellular RNA samples or virion
RNA. This suggests that changes in proportions of S RNA species
present in infected-cells or packaged into a virion were associated
with the reconfigured S-RNA. However, there was no significant
difference in the proportion of genomic RNA present in total cell
RNA extracts compared to that detected in virions: that is,
whatever polarity of viral RNA segment that was most abundant
within the total cell RNA population was also the prevalent species
packaged in virus particles (Table 1).
Discussion
The ambisense coding strategy adopted by some members of
the Bunyaviridae and the Arenaviridae is an intriguing way of
regulating temporal gene expression [22,23]. The ambisense
RVFV S segment encodes the N and NSs proteins that are
Table 1. Summary of qRT-PCR analysis.
S Segment
Samples Compared C6/36 U4.4 Ae BHK
rMP12 Virion vs. rMP12:S-Swap Virion YESa YES YES YES
rMP12 Virion vs. MP12 Total NOb NO NO NO
rMP12:S-Swap Virion vs. rMP12:S-Swap Total NO NO NO NO
rMP12 Total vs. rMP12:S-Swap Total YES YES YES YES
M Segment
Samples Compared C6/36 U4.4 Ae BHK
rMP12 Virion vs. rMP12:S-Swap Virion NO NO NO NO
rMP12 Total vs. rMP12:S-Swap Total NO NO NO NO
a, significantly different, p,0.05 (see Methods for details).
b, not significantly different,
doi:10.1371/journal.ppat.1003922.t001
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translated from individual subgenomic mRNAs. The N mRNA is
transcribed from the genomic S segment whereas the NSs mRNA
is transcribed from the antigenome S segment (Figure 1A). In this
study, we investigated the consequences of swapping the N and
NSs coding sequences on the S segment by directly substituting the
N ORF into the NSs locus and the NSs ORF into the N locus
(Figure 1). We were able to recover, by reverse genetics, a virus
that contained the modified S segment, designated rMP12:S-
Swap. This strategy left the 39, 59, and intergenic untranslated
regions untouched, though it is possible that cis-acting signals
spanning untranslated and coding sequences (e.g. for packaging or
transcription termination) could be disrupted. The replication
kinetics of rMP12:S-Swap, the parental virus rMP12, and
recombinant viruses in which the NSs ORF was replaced with
that of the eGFP (rMP12DNSs:eGFP and rMP12:S-SwapDNS-
s:eGFP) were compared in a range of mammalian and insect cell
lines. Viruses that contained the reconfigured genomic S segment
gave titres 10- to 1000-fold lower than the corresponding viruses
with the normal S segment configuration (rMP12 or
rMP12DNSs:eGFP) in all cell lines tested (Figure 2A, 2C).
Reduced growth appeared to be correlated with the marked
reduction in the amount of N protein produced over 48 h in
rMP12:S-Swap- and rMP12:S-SwapDNSs:eGFP-infected cells
compared to that of the parental viruses. Although synthesis of
the Gn glycoprotein was less in reconfigured viruses early in
infection, this appeared to reflect their slower replication kinetics.
At 18 and 24 h p.i. the titre of rMP12:S-Swap was approximately
1000-fold less than rMP12 and Gn was weakly detected. However,
by 48 h p.i., there was only a 10-fold difference between the virus
titres, and much less difference in the intensity of Gn bands
(Figure 3A).
Initially, it was thought that the decrease in the amount of N
produced in rMP12:S-Swap infected cells could have been due to
the increased and earlier expression of the NSs protein. Previous
work in our laboratory had shown that the NSs protein of RVFV
could inhibit a Renilla-based minigenome in a dose dependent
manner [14], implying a regulatory role of NSs in RVFV
polymerase activity. However, the NSs-deleted virus rMP12:S-
SwapDNSs:eGFP also showed a reduced amount of N protein
(Figure 3A) indicating that NSs was not involved.
A direct visual comparison of the differential protein expression
between the parental and reconfigured viruses was provided by
observing eGFP fluorescence in rMP12DNSs:eGFP- and
rMP12:S-SwapDNSs:eGFP-infected BHK-21 monolayers: eGFP
fluorescence was more intense in rMP12:S-SwapDNSs:eGFP-
compared to that of rMP12DNSs:eGFP-infected cells. This
indicates that the authentic MP12 ‘N promoter’ sequence
(antigenomic 59 UTR) driving eGFP expression in rMP12:S-
SwapDNSs:eGFP is much stronger than that of the authentic
MP12 ‘NSs promoter’ sequence (genomic 59 UTR). Earlier studies
have reported that the UTRs on different segments have different
promoter strengths [25,35–40], and though a direct comparison of
N and NSs promoter strengths was not obtained, it was observed
that NSs mRNA levels were significantly less than those of N
mRNA in infected cells. Thus differences between promoter
strengths on genomic and antigenomic RNAs are likely to be
responsible for the difference in N protein levels observed between
parental and reconfigured viruses, rather than any specific
inhibition of N protein production.
Previous reports have suggested potential roles for the
nonstructural proteins of bunyaviruses in the maintenance of a
virus in the natural infectious cycle, persistence in infected insect
cells, and dissemination of a virus throughout an infected mosquito
[29,31,41–45]. Therefore we investigated how the differential
expression of NSs affected the ability of the virus to replicate in
cultured mosquito cells. We found that NSs protein was readily
detectable in rMP12-infected A. albopictus C6/36 cells, as was the
NSs subgenomic mRNA (Figure 8B) but neither NSs nor eGFP
could be detected in A. albopictus U4.4 or A. aegypti Ae cells that had
been infected with rMP12 or rMP12DNSs:eGFP respectively.
Similarly NSs mRNA could not be detected by Northern blotting
(Figure 8B). This is in line with published results showing that in
U4.4 and another A. aegypti cell line, Aag2, NSs expression is down
regulated at the transcriptional level by a Dicer-2 mediated RNAi
response. This RNAi response, characterised by 21-nt long
viRNAs, is non-functional in C6/36 cells, due to a deletion in
the dicer-2 gene, and may explain why NSs can be expressed
during infection (Figure 3C) [31,46]. The difference in RNAi
responses is presumably the reason why rMP12 grows to higher
titres in C6/36 cells (Figure 2C) compared to other mosquito lines.
Unexpectedly, there was no detectable eGFP expression in C6/36
cells infected with rMP12DNSs:eGFP. Despite not having a
functional Dicer-2 protein, C6/36 cells are able to mount a Piwi-
mediated RNAi response [47–49], characterised by 24–30-nt long
viRNAs, and in the absence of NSs expression (as in
rMP12DNSs:eGFP-infected cells) the Piwi-pathway may be
sufficient to degrade the eGFP-mRNA [31].
When the three insect cell lines were infected with either
rMP12:S-Swap or rMP12:S-SwapDNSs:eGFP, the NSs protein
was detected in cell lysates by western blotting or eGFP
fluorescence was observed microscopically as appropriate. By
contrast, N protein levels were much reduced, particularly in U4.4
and Ae cells, compared to infection with parental viruses
(Figure 3C, 3D). Based on the western and northern blot data,
it is not possible to determine whether RNAi contributes to the
down-regulation of N observed in U4.4 and Ae cells, or whether
the lower amounts of N just reflect the weaker promoter driving
transcription of its mRNA. The study by Le´ger et al. [31]
revealed hot spots for viRNA targets amongst the genome
segments, one of which appears to be in the antigenomic sense
NSs region that could degrade its mRNA. It would be instructive
to compare the profiles of small RNAs produced in mosquito
cells infected with rMP12 and rMP12:S-Swap to investigate
whether the pattern of S segment viRNA hot spots differs with
the reconfigured S RNA.
Down-regulation of NSs by RNAi is thought necessary for
RVFV to establish persistence in mosquito cells, as a persistent
infection could not be established by the ZH548 strain in Dicer-2
deficient C6/36 cells [31]. Accordingly, persistent infections of
U4.4 cells and Ae cells were readily established by rMP12 and no
NSs protein could be detected. However, we were able also to
establish persistent infection of C6/36 cells with rMP12; NSs levels
markedly decreased at each passage of the cells, perhaps mediated
by piRNAs. The MP12 strain contains mutations on all three
segments that attenuate replication in mammalian cells [50]; it
would be of interest to determine which mutations are associated
with the ability to establish persistence in A. albopictus C6/36 cells.
However, when C6/36 cells were infected with rMP12:S-Swap,
western blotting showed that NSs was hyper-expressed, and many
cells detached from the monolayer during infection. By passage 3
all the cells had been killed by the infection and hence persistence
could not be maintained. U4.4 cells also showed similar evidence
of cytopathic effect, and cells did not survive beyond passage 5.
Thus we suggest that the RNAi response is able to modulate
though not ablate NSs expression. Taken together, the data
indicate that high levels NSs are toxic to mosquito cells, perhaps
through a comparable transcriptional inhibition as occurs in
mammalian cells. The RNAi system in U4.4 cells normally
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represses NSs expression almost completely when infected with
virulent or attenuated strains; initially, it seems able to control NSs
expression sufficiently to enable cell survival when infected with
rMP12:S-Swap. However, accumulation of NSs after a few
passages resulted in cell death. In this regard analysis of viRNA
populations in U4.4 cells persistently infected with rMP12:S-Swap
would be of interest. We were unable to establish persistence in Ae
cells infected with rMP12:S-Swap. It is possible that the RNAi
response is even more robust in these cells compared to U4.4. cells,
and as no cytopathic effects were seen following infection with
rMP12:S-Swap, we presume that the amount of N protein
produced was insufficient to enable a productive replication cycle
to begin.
The NSs protein characteristically forms nuclear filaments in
infected mammalian cells [30,51,52], and filament formation is
independent of other viral proteins [53]. A consequence of the
increased expression of NSs by rMP12:S-Swap was that the
filaments were much thicker than those produced by rMP12,
and in addition there was an increased abundance of NSs
protein in the cytoplasm of rMP12:S-Swap-infected Vero-E6
cells at later times during infection. In contrast, although NSs
was detected in the nuclei of infected mosquito cells, no filament
formation was observed. Interestingly, the NSs protein expressed
by the virulent ZH548 strain of RVFV did form intranuclear
filaments in infected A. albopictus C6/36 cells [31] whereas the
NSs of the attenuated MP12 strain appeared to form aggregates
(Figure 4C). There is a single amino acid difference between the
two NSs proteins (residue 160 is valine in ZH548 and alanine in
MP12; [50]) but in the absence of structural information on NSs
it is not possible to understand how this residue affects filament
formation.
In mammalian cells a major function of the NSs protein is to
elicit global inhibition of host cell transcription, mediated by
effects on transcription factor TFIIH subunits [8,9]. We
therefore examined the effect that excess NSs (produced during
rMP12:S-Swap infection) had on the ability of the virus to shut
off protein or RNA synthesis (Figure 6). Surprisingly, there was
no difference in the ability of rMP12:S-Swap to abrogate protein
synthesis compared to the parental virus, despite a very obvious
over-expression of the NSs protein at 16 and 24 h p.i. in
rMP12:S-Swap-infected cell lines. This suggests that the amount
of NSs produced in an rMP12-infected cell is already at a
saturating level and that any excess NSs produced (such as
during rMP12:S-Swap infection) cannot increase the rate at
which global host cell protein synthesis inhibition occurs
(Figure 6A). Inhibition of RNA synthesis was strongly correlated
with formation of nuclear NSs filaments. A marked reduction in
RNA synthesis was seen in infected-cells upon detection of
nuclear localised NSs staining, indicating that NSs expressed by
rMP12:S-Swap was able to inhibit host cell RNA synthesis in the
same manner as that of rMP12, in agreement with previous
reports [9,12].
In both rMP12- and rMP12:S-Swap-infected cells we observed
rapid depletion of p62, the timing of which correlated with
expression of NSs. However, there was no appreciable reduction
in the level of PKR in the presence of enhanced NSs expression in
rMP12:S-Swap-infected cells. PKR degradation in RVFV-infected
cells is mediated by NSs via the ubiquitin cellular proteasomal
pathway [10,11]. Therefore, our data suggest that in rMP12:S-
Swap-infected cells this pathway could be blocked somehow,
perhaps due to an overwhelming amount of NSs being present in
the cytoplasmic compartment of the cell (visualised in Figure 4A).
Our data are also consistent with a recent report that p62 and
PKR are degraded in virus-infected cells independently of one
another [12]. In this paper the authors described a recombinant
virus rMP12-NSsR173A, which expressed NSs containing substi-
tution of amino acid 173, that inhibited host RNA synthesis and
IFN-b gene expression, but was unable to degrade PKR.
Furthermore, the mutant NSs filaments appeared different from
those of parental NSs, forming an irregular mosaic-like pattern.
The authors suggested that the PKR degradation might involve a
domain in NSs containing residue 173. The phenotype of
rMP12:S-Swap is remarkably similar to that of rMP12-
NSsR173A, and perhaps the over-expression of NSs by the
former virus sterically inhibits the interaction needed for PKR
degradation. Alternatively, the delay in inhibition of transcription
observed in rMP12:S-Swap infected cells may allow sufficient
expression of a factor that prevents PKR degradation once NSs is
expressed.
Finally, to assess whether the changes in NSs protein expression
were represented at the transcriptional level we examined the
production of viral RNAs in virus-infected cells. There was
substantially more NSs mRNA transcribed from the viral
genomic S RNA of rMP12:S-Swap than from the viral anti-
genomic S RNA of rMP12 suggesting that this is basis for the
increased NSs protein production seen during rMP12:S-Swap
infection (Figure 8A). This effect was particularly evident when
examining the subgenomic N and NSs mRNAs produced during
infection of insect cells. As discussed earlier, it appears that the
insect RNAi response targets the NSs mRNA of rMP12 and
reduces the cellular concentration of any mRNA originating
from that locus: NSs in rMP12 and N in rMP12:S-Swap
(Figure 8B).
Importantly, there also appeared to be a substantial difference
in the relative abundance and polarity of RNA packaged into
progeny virions between the two viruses. rMP12 packages more
genomic than antigenomic S RNA whereas for rMP12:S-Swap the
opposite was apparent. This indicates that the panhandle structure
formed by the 39 and 59 termini of each RNA segment is not the
only prerequisite for the packaging of specific polarities of viral
RNA, as the UTRs of both viruses have remained unchanged
[54,55]. It is possible that a packaging signal (RNA sequence or
structure) resides within the anti-sense N coding sequence which
determines what particular polarity of RNA is incorporated into a
virus particle. On the other hand, as the population of RNAs, be it
genome or antigenome, present in the infected cell reflected that
packaged into virions, there may not be a selective packaging
mechanism for one polarity of RNA over another, but rather it is a
stochastic mechanism that packages the most abundant viral RNA
species into the virus particle. Additional work is underway to
investigate polarity-specific packaging further.
In conclusion, by transposing the relative orientations of N and
NSs ORFs on the RVFV S genome segment, we have generated a
virus whose growth is attenuated in cell culture and whose
replication is cytotoxic in cultured mosquito cells. It would be of
interest to assess whether rMP12:S-Swap or derivatives thereof
could be useful for vaccine development. For instance, a version
expressing a marker epitope in place of NSs would likely be
attenuated in animals and capable of inducing protective
immunity, as demonstrated for other NSs-deleted viruses
[15,16], and antibodies to the highly-expressed epitope could be
useful in differentiating infected from vaccinated animals (DIVA).
Alternatively, a protective antigen from another pathogen could be
over-expressed instead of NSs to create a divalent vaccine. On the
other hand, if over-expression of NSs results in death of an infected
mosquito, this feature might be exploited to generate non-
transmissible live vaccines. Such possibilities warrant further
investigation.
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Materials and Methods
Cells and viruses
Vero-E6, A549 and A549-NPro [56] cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS). BSR-T7/5 cells [57], which stably
express T7 RNA polymerase, were grown in Glasgow minimal
essential medium (GMEM) supplemented with 10% FCS, 10%
tryptose phosphate broth (TPB) and 1 mg/ml G418. BHK-21 cells
were grown in GMEM supplemented with 10% newborn calf
serum (NCS) and 10% TPB. All mammalian cell lines were grown
at 37uC with 5% CO2 unless otherwise stated.
Aedes albopictus C6/36 and U4.4 and Aedes aegypti Ae cells were
grown at 28uC in Leibovitz 15 medium (Gibco) supplemented with
10% fetal calf serum (FBS) and 10% tryptose phosphate broth, as
described previously [29].
All experiments with infectious virus were conducted under
BSL-3 conditions. Stocks of recombinant viruses were grown in
BHK-21 cells at 33uC by infecting at a multiplicity of infection
(MOI) of 0.01 and harvesting the culture medium at 72 h post
infection (p.i.).
Plasmids
Plasmids for the recovery of RVFV have been described
previously [27]. pTM1-L and pTM1-N contain the RVFV MP12
L and N ORFs under the control of T7 promoter and
encephalomyocarditis virus internal ribosome entry site sequence;
pTVT7-GS, pTVT7-GM and pTVT7-GL contain full-length
cDNAs to the RVFV strain MP12 antigenome segments flanked
by T7 promoter and hepatitis delta ribozyme sequences. Plasmid
pTVT7-GS:S-Swap contains a full-length cDNA to the RVFV S
segment in which the two S segment derived ORFs encoding the
N and NSs proteins have been swapped, thereby creating a
genomic S segment in which the N protein is expressed at the NSs
locus and the NSs protein at the N locus. The swapped genomic
segment was synthesised by GenScript USA Inc. and cloned into
pTVT7 using BbsI restriction sites. The constructs pTVT7-
GSDNSs:eGFP or pTVT7-GS:S-SwapDNSs:eGFP were created
by replacing the NSs coding sequences with that of the enhanced
green fluorescent protein (eGFP).
Generation of recombinant viruses from cDNA
Recombinant RVFV were generated by transfecting 76105
BSR-T7/5 cells with 0.5 mg each pTM1-L and pTM1-N, and
1 mg each pTVT7-based plasmid expressing the viral antigenomic
segments as appropriate, using 3 ml Lipofectamine 2000 (Invitro-
gen) per mg of DNA. After 5 to 7 days, when extensive cpe was
observed, the virus-containing supernatants were collected,
clarified by low speed centrifugation and stored at 280uC.
Virus titration by plaque assay
BHK-21 cells were infected with serial dilutions of virus and
incubated under an overlay consisting of GMEM supplemented
with 2% NCS and 0.6% Avicel (FMC BioPolymer) at 37uC for 4
days. Cell monolayers were fixed with 4% paraformaldehyde and
plaques were visualized by Giemsa staining.
Western blotting
At different time points after infection cell lysates were prepared
by the addition of 300 ml lysis buffer (100 mM Tris-HCl, pH 6.8;
4% SDS; 20% glycerol; 200 mM DTT, 0.2% bromophenol blue
and 25 U/ml Benzonase (Novagen)) and proteins separated on a
SDS-4–12% gradient polyacrylamide gel (Invitrogen). Proteins
were transferred to a Hybond-C Extra membrane (Amersham),
and the membrane was blocked by incubating in saturation buffer
(PBS containing 5% dry milk and 0.1% Tween 20) for 1 h. The
membrane was reacted with anti-N and anti-NSs polyclonal rabbit
antibodies [14], an anti-Gn antibody (ProSci Inc.), an anti-eGFP
antibody (Invitrogen) or an anti-tubulin monoclonal antibody
(Sigma). This was followed by incubation with either horseradish
peroxidase (HRP)-labelled anti-rabbit (Cell Signalling Technology)
or anti-mouse (Sigma) antibodies. Visualization of detected
proteins was achieved using SuperSignal WestPico chemilumines-
cent substrate (Pierce), followed by exposure to x-ray film.
Metabolic radiolabeling
A549 or A549 NPro cells were infected with recombinant
viruses at a MOI of 3. At the time points indicated, cells were
incubated in starvation media lacking methionine for 30 min,
washed, and then labelled with [35S] methionine/cysteine
(30 mCi/ml; Amersham Pharmacia Biotech) for 2 h. Cell lysates
were prepared by the addition of 300 ml lysis buffer (100 mM Tris-
HCl, pH 6.8; 4% SDS; 20% glycerol; 200 mM DTT, 0.2%
bromophenol blue and 25 U/ml Benzonase (Novagen)) and
proteins separated by SDS-PAGE as described above. Visualisa-
tion of labelled proteins was achieved by exposure to a Storm840
Phospho-imager (Molecular Dynamics) or to X-ray film.
Biological assay for interferon production
A549 cells in 35 mm dishes were infected with 5 PFU/cell of
the recombinant viruses and incubated at 37uC for 18 h. The
medium was removed and treated with UV light to inactivate any
virus [34] and two-fold serial dilutions of the medium were applied
to A549-NPro cells for 24 h. The cells were then infected
with interferon-sensitive encephalomyocarditis virus (EMCV;
0.05 PFU/cell), and cells incubated for 4 days at 37uC. The cells
were fixed with formaldehyde and stained with Giemsa stain to
monitor development of CPE. The relative IFN units (RIU) are
expressed as 2N where N is the number of two-fold dilutions that
protect the reporter cells.
Immunofluorescent detection of host RNA synthesis
A549 cells were grown on glass cover-slips (13 mm diameter),
and either infected with recombinant viruses, mock-infected or
mock-infected and treated with Actinomycin D (5 mg/ml). The
uridine analogue 5-ethynyl uridine (EU) was added to the culture
medium for 1 h prior to harvest at the time points indicated,
following the manufacturer’s instructions (Click-iT RNA AF488
Imaging Kit; Invitrogen). Briefly, after 5-EU treatment, cells were
permeabilized in 0.5% Triton X-100 in PBS and then incubated
with the Click-iT reaction cocktail. Following treatment cells were
reacted with RVFV anti-NSs primary (1:250) and Alexa Fluor 633
anti-rabbit (1:200) secondary antibodies. Localisation of the
fluorescently labelled proteins and RNA was examined at various
times post infection using a Zeiss LSM confocal microscope.
Northern blotting and reverse transcription-PCR
BHK-21 cells were infected at a MOI of 1 and total cellular
RNA was extracted at 48 h p.i. using TRIzol reagent (Invitrogen).
Four micrograms of RNA was electrophoresed through a 1.2%
agarose gel in TAE buffer [58] and then transferred to a positively
charged nylon membrane (Roche). For the isolation of RNA from
virus particles, RNA from 16106 virions of either rMP12 or
rMP12:S-Swap virus stocks were extracted using the QIAamp
Viral RNA Minikit (Qiagen). Equal volumes of eluted RNA were
then electrophoresed through a 1.2% TAE gel and transferred to a
positively charged nylon membrane as described above. The
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membranes were hybridized with digoxigenin-labelled RNA
probes complementary to genome sense (2) or anti-genome sense
(+) sequences representing Gn, N or NSs protein coding regions
(150 ng of each probe); detection was carried out using a DIG
Northern Starter Kit (Roche).
For reverse transcription-PCR (RT-PCR), 1 mg of total cellular
RNA was mixed with a segment-specific oligonucleotide, 0.5 mM
46 dNTP mix (Promega), 40 U rRNasin (Promega) and 200 U
M-MLV reverse transcriptase (Promega), and incubated at 42uC
for 3 hours. The resulting cDNA was used in PCR reactions with
primers as described in Results, and the products were visualized
by agarose gel electrophoresis. Details of oligonucleotides used can
be found in Table S1.
Quantitative RT-PCR
Total cell RNA or virion RNA was extracted as described
above, the resulting RNA quantified (Nanodrop Spectrophotom-
eter; Thermo Scientific) and standardised to 2 ng/ml. Reverse
transcription was performed as described above with an additional
final incubation step of 90uC for 10 minutes to inactivate enzyme.
Each reaction included a segment and strand-specific oligonucle-
otide (Table 2). A standardised control reaction was performed on
in-vitro transcribed genomic and anti-genomic RNA to allow for
normalisation of differences in experimental sensitivity. Details of
oligonucleotides used in qPCR reactions can be found in Table 2.
Quantitative PCR (qPCR) was carried out using MESA Blue
qPCR MasterMix for SYBR Assay (Eurogentec) on a ABI 7300
platform (Applied Biosystems). Each reaction was performed in a
10 ml volume (8.4 ml qPCR MasterMix, 0.3 ml strand specific
primer (10 mM) and 0.3 ml of TAG-primer (10 mM) and 1 ml
cDNA template). Each reaction contained the opposing primer to
the one used in the RT reaction and the TAG-primer (e.g. the
rMP12 S genomic RNA RT-primer was N REV-TAG and the
qPCR primers were N FWD and TAG-primer). The cycling
parameters were 50uC for 2 minutes, 95uC for 10 minutes,
followed by 40 cycles of 95uC for 15 s and 60uC for 60 s. A
dissociation stage was included at the end of each reaction as a
quality control step. A melt curve analysis at the end of each assay
consisted of 95uC for 15 seconds, 60uC for 1 minute before
increasing temperature to 95uC at 0.1uC per second. Each
reaction was performed in triplicate with a mean Ct value
calculated post assay. Each cell type and virus combination was
tested a minimum of five times with unique infections and RNA
preparations.
Ct values obtained for genome and antigenome assays were
compared to determine the ratio of genome to antigenome in the
original RNA preparation. Ct values were corrected using data
from the segment specific standard curves. Differences in Ct values
were calculated (genome Ct – antigenome Ct). The square root of
the square of this number was calculated to remove any negative
values. The relative amount difference between the two values was
calculated using the formula x= e(0.6931 y) where y is the difference
in Ct values.
The calculated figure gives the relative amount difference
between the genomic and antigenomic S or M segments in the
original RNA sample. From this a percentage was be calculated
(% genome= x/(x+1) ) which was used in all further statistics and
figures. Graphs were produced, and one-way ANOVA with
Tukey’s multiple comparison post-test were performed, using
GraphPad Prism version 5.0a for Mac OS X (GraphPad Software,
La Jolla California USA, www.graphpad.com). Significance was
set at p,0.05.
Indirect immunofluorescent staining and live cell
imaging
Vero-E6, C6/36, U4.4 or Ae cells were grown on glass
coverslips (13 mm diameter), infected with recombinant viruses
and fixed at the time points indicated with 4% paraformaldehyde
in PBS. After permeabilization with 0.1% Triton X-100 in PBS
the cells were reacted with specific primary antibodies, followed by
secondary antibody conjugates. Localisation of the fluorescently
labelled proteins was examined at various times post infection
using a Zeiss LSM-510 confocal microscope. The widths of 50
rMP12 or rMP12:S-Swap NSs filaments were measured using the
LSM Image Browser Software (Carl Zeiss MicroImaging GmbH)
and the results presented as the mean and standard error of the
mean of the two groups.
Images of infected cell monolayers were visualised for eGFP
fluorescence using an EVOS FL Cell Imaging System (AMG,
Invitrogen).
Table 2. Oligonucleotides used in reverse transcription and qRT-PCR reactions.
Oligo Sequence 59-39
Genome Position (Genomic
Sense)
S Segment
N FWD AACTCTACGGGCATCAAACC 1539–1558a
N REV-TAG GGCCGTCATGGTGGCGAATAAGAGCTTGCGATCCAGTT 1620–1639a
NSs FWD-TAG GGCCGTCATGGTGGCGAATGGACTCCTTTGCTGGCTTAC 502–521a
NSs REV GCACTGTACGTGAGCAACCT 597–616a
M Segment
M FWD CCGGTGCAACTTCAAAGAGT 10–29b
M REV AGGCAGCAGCAGTCTCAAGT 90–109b
M FWD-TAG GGCCGTCATGGTGGCGAATCCGGTGCAACTTCAAAGAGT
M REV-TAG GGCCGTCATGGTGGCGAATAGGCAGCAGCAGTCTCAAGT
TAG Oligo GGCCGTCATGGTGGCGAAT
aFrom Rift Valley fever virus strain MP-12 segment S, DQ380154.
bFrom Rift Valley fever virus strain MP-12 segment M, DQ380208.
Tagged oligonucleotides were used for strand specific reverse transcription. The TAG sequence is underlined.
doi:10.1371/journal.ppat.1003922.t002
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Supporting Information
Figure S1 Sensitivity of anti-N and anti-NSs antibodies.
BSR-T7/5 cells were transfected with either 0.5 or 1.0 mg of
expression constructs pTM1-N or pTM1-NSs expressing the
MP12 N or NSs proteins respectively. 48 h post transfection, cell
lysates were prepared by the addition of 300 ml lysis buffer
(100 mM Tris-HCl, pH 6.8; 4% SDS; 20% glycerol; 200 mM
DTT, 0.2% bromophenol blue and 25 U/ml Benzonase (Nova-
gen)) and proteins separated on a 4–12% SDS-PAGE gel
(Invitrogen). Proteins were transferred to a Hybond-C Extra
membrane (Amersham), and the membrane was blocked by
incubating in saturation buffer (PBS containing 5% dry milk and
0.1% Tween 20) for 1 h. The membrane was reacted with anti-N
and anti-NSs polyclonal antibodies at concentrations of 1:1000,
5000, 10000 or 20000 for 1 h at room temperature. This was
followed by incubation with horseradish peroxidase (HRP)-
labelled anti-rabbit (Cell Signalling Technology). Visualization of
detected proteins was achieved using SuperSignal WestPico
chemiluminescent substrate (Pierce), followed by exposure to x-
ray film.
(DOCX)
Figure S2 Standard curves for qRT-PCR. Standard Curves
for the S segment genome/antigenome and M segment genome/
antigenome. 10-fold serial dilutions from in-vitro transcription
generated RNAs (of known concentrations and hence copy
number) were used to construct the curves. Calculation shows
the gradient and R2 value for the curve.
(DOCX)
Figure S3 Melt curve analysis of PCR products. Melt
curve analysis on the qPCR products for S segment genome (A)
and antigenome (B), and M segment genome (C) and antigenome
(D). The Tm of the S segment genome and antigenome assays were
80.8uC and 82.3uC respectively. The M segment genome and
antigenome assays utilized the same primers and produced similar
PCR products which ensures that the Tm’s are identical, 79.3uC
(DOCX)
Table S1 Oligonucleotides used for RT-PCR.
(DOCX)
Table S2 Validation parameters. Validation parameters of
the standard curves. Amplification efficiency was calculated using
the following function: E=21+10(21/slope)
(DOCX)
Table S3 Ratio of genome to antigenome (shown as a
percentage of total) from the qPCR assays for virion
extraction RNA. Data collected for the repeated qPCR assays
for BHK-21, C6/36, U4.4, and Ae cells infected with both rMP12
and rMP12:S-Swap viruses. The mean value is for each sample set
is shown at the base of the table.
(DOCX)
Table S4 Ratio of genome to antigenome (shown as a
percentage of total) from the qPCR assays for total
extraction RNA. Data collected for the repeated qPCR assays
for BHK-21, C6/36, U4.4, and Ae cells infected with both rMP12
and rMP12:S-Swap virus. The mean value is for each sample set is
shown at the base of the table.
(DOCX)
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